📈MarketsSpyre Therapeutics Outlines Strategy at UBS Conference to Overcome IBD Treatment Limits
Spyre Therapeutics CEO Cameron Turtle presented the company's roadmap at the UBS Global Biopharma Conference 2026, aiming to push past traditional therapeutic limits in t…